EBACW
Closed
European Biotech Acquisition Corp
0.52
+0.01 (+1.94%)
Last Update: 02 Mar 2023 23:56:00
Yesterday: 0.515
Day's Range: 0. - 0.
Send
sign up or login to leave a comment!
When Written:
0.52
European Biotech Acquisition Corp is a special purpose acquisition company (SPAC) that was formed in 2021 with the aim of acquiring and merging with a biotechnology company in Europe. The company is based in Amsterdam, Netherlands and is led by a team of experienced biotech investors and executives. The company raised $125 million in its initial public offering (IPO) in March 2021 and is currently seeking potential acquisition targets in the biotech industry. The company's focus is on companies that are developing innovative therapies for unmet medical needs in areas such as oncology, rare diseases, and gene therapy. European Biotech Acquisition Corp is listed on the NASDAQ under the ticker symbol EBACU.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








